Purpose of Review
Adolescents and young adults (AYAs) with cancer are a vulnerable population with unique needs that are under-recognized and often overlooked by healthcare providers. This review focuses on identifying and meeting some of those needs including adherence to treatment, financial implications, impact on fertility and intimacy, issues with work/school, isolation, challenges with re-entry, and long-term side effects and survivorship.
Survival rates have not improved in adolescents and young adults with cancer at the same rate as in children and older adults (the so called “AYA gap”). Restricted or delayed access to care and inconsistent cancer treatment and follow-up care contribute to this. Importantly, fertility preservation options have broadened and efforts to provide age appropriate counseling prior to treatment have improved. Additionally, AYAs face a variety of psychosocial issues while dealing with a cancer diagnosis during critical developmental years, and yet data pertaining to the successful identification and management of these issues is lacking. As a result, there has been recent increasing awareness that this patient population warrants strong advocates, additional research, and requires age group specific resources to be successful in navigating their cancer experience during treatment and into survivorship care.
Members of the healthcare team should familiarize themselves with the unique needs of AYA cancer patients to provide optimal patient care. In order to build upon early progress, this group calls for additional study particularly when it comes to barriers to enrollment for AYA-specific research (including clinical trials), recognizing psychosocial needs (both during and after treatment), transition planning for returning to life after cancer, and managing long-term effects of treatment (including neuro cognitive changes). In addition, access to financial resources and appropriate mental health support needs to be improved.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Smith AW, Seibel NL, Lewis DR, Albritton KH, Blair DF, Blanke CD, et al. Next steps for adolescent and young adult oncology workshop: an update on progress and recommendations for the future. Cancer. 2016;122(7):988–99. https://doi.org/10.1002/cncr.29870.
Sender L, Zabokrtsky KB. Adolescent and young adult patients with cancer: a milieu of unique features. Nat Rev Clin Oncol. 2015;12(8):465–80. https://doi.org/10.1038/nrclinonc.2015.92.
Keegan TH, Ries LA, Barr RD, Geiger AM, Dahlke DV, Pollock BH, et al. Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults. Cancer. 2016;122(7):1009–16. https://doi.org/10.1002/cncr.29869.
Butow P, Palmer S, Pai A, Goodenough B, Luckett T, King M. Review of adherence-related issues in adolescents and young adults with cancer. J Clin Oncol. 2010;28(32):4800–9. https://doi.org/10.1200/JCO.2009.22.2802.
Kato PM, Cole SW, Bradlyn AS, Pollock BH. A video game improves behavioral outcomes in adolescents and young adults with cancer: a randomized trial. Pediatrics. 2008;122(2):e305–17. https://doi.org/10.1542/peds.2007-3134.
Perales MA, Drake EK, Pemmaraju N, Wood WA. Social media and the adolescent and young adult (AYA) patient with cancer. Curr Hematol Malig Rep. 2016;11(6):449–55. https://doi.org/10.1007/s11899-016-0313-6.
Peate M, Meiser B, Friedlander M, Zorbas H, Rovelli S, Sansom-Daly U, et al. It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer--an Australian fertility decision aid collaborative group study. J Clin Oncol. 2011;29(13):1670–7. https://doi.org/10.1200/JCO.2010.31.2462.
Yeomanson DJ, Morgan S, Pacey AA. Discussing fertility preservation at the time of cancer diagnosis: dissatisfaction of young females. Pediatr Blood Cancer. 2013;60(12):1996–2000. https://doi.org/10.1002/pbc.24672.
• Patel P, Kohn TP, Cohen J, Shiff B, Kohn J, Ramasamy R. Evaluation of reported fertility preservation counseling before chemotherapy using the quality oncology practice initiative survey. JAMA Netw Open. 2020;3(7):e2010806. https://doi.org/10.1001/jamanetworkopen.2020.10806This cross sectional study examined the frequency at which men and women of reproductive age received fertility counseling before chemotherapy and found further awareness and improved implementation of fertility risk guidelines is needed.
Saito K, Suzuki K, Iwasaki A, Yumura Y, Kubota Y. Sperm cryopreservation before cancer chemotherapy helps in the emotional battle against cancer. Cancer. 2005;104(3):521–4. https://doi.org/10.1002/cncr.21185.
Ginsberg JP, Li Y, Carlson CA, Gracia CR, Hobbie WL, Miller VA, et al. Testicular tissue cryopreservation in prepubertal male children: an analysis of parental decision-making. Pediatr Blood Cancer. 2014;61(9):1673–8. https://doi.org/10.1002/pbc.25078.
Morgan S, Anderson RA, Gourley C, Wallace WH, Spears N. How do chemotherapeutic agents damage the ovary? Hum Reprod Update. 2012;18(5):525–35. https://doi.org/10.1093/humupd/dms022.
Anderson RA, Nelson SM, Wallace WH. Measuring anti-Mullerian hormone for the assessment of ovarian reserve: when and for whom is it indicated? Maturitas. 2012;71(1):28–33. https://doi.org/10.1016/j.maturitas.2011.11.008.
Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101(9):3373–85. https://doi.org/10.1182/blood-2002-07-2231.
Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res. 1974;59(3):665–78.
van der Kaaij MA, van Echten-Arends J, Simons AH, Kluin-Nelemans HC. Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol Oncol. 2010;28(4):168–79. https://doi.org/10.1002/hon.939.
Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One. 2010;5(1):e8772. https://doi.org/10.1371/journal.pone.0008772.
Anderson RA, Cameron DA. Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab. 2011;96(5):1336–43. https://doi.org/10.1210/jc.2010-2582.
Anderson RA, Rosendahl M, Kelsey TW, Cameron DA. Pretreatment anti-Mullerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer. Eur J Cancer. 2013;49(16):3404–11. https://doi.org/10.1016/j.ejca.2013.07.014.
Ruddy KJ, O'Neill A, Miller KD, Schneider BP, Baker E, Sparano JA, et al. Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103. Breast Cancer Res Treat. 2014;144(3):591–7. https://doi.org/10.1007/s10549-014-2891-0.
Chemaitilly W, Sklar CA. Endocrine complications in long-term survivors of childhood cancers. Endocr Relat Cancer. 2010;17(3):R141–59. https://doi.org/10.1677/ERC-10-0002.
Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T, et al. Gonadal shielding to irradiation is effective in protecting testicular growth and function in long-term survivors of bone marrow transplantation during childhood or adolescence. Bone Marrow Transplant. 2007;39(8):483–90. https://doi.org/10.1038/sj.bmt.1705612.
Cakmak H, Katz A, Cedars MI, Rosen MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013;100(6):1673–80. https://doi.org/10.1016/j.fertnstert.2013.07.1992.
Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013;99(6):1476–84. https://doi.org/10.1016/j.fertnstert.2013.03.029.
Edgar DH, Gook DA. A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum Reprod Update. 2012;18(5):536–54. https://doi.org/10.1093/humupd/dms016.
Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Sanchez Serrano M, Schmidt KT, et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013;99(6):1503–13. https://doi.org/10.1016/j.fertnstert.2013.03.030.
Terenziani M, Piva L, Meazza C, Gandola L, Cefalo G, Merola M. Oophoropexy: a relevant role in preservation of ovarian function after pelvic irradiation. Fertil Steril. 2009;91(3):935 e15–6. https://doi.org/10.1016/j.fertnstert.2008.09.029.
Behringer K, Wildt L, Mueller H, Mattle V, Ganitis P, van den Hoonaard B, et al. No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Ann Oncol. 2010;21(10):2052–60. https://doi.org/10.1093/annonc/mdq066.
Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA. 2011;306(3):269–76. https://doi.org/10.1001/jama.2011.991.
Del Mastro L, Ceppi M, Poggio F, Bighin C, Peccatori F, Demeestere I, et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev. 2014;40(5):675–83. https://doi.org/10.1016/j.ctrv.2013.12.001.
Gerber B, von Minckwitz G, Stehle H, Reimer T, Felberbaum R, Maass N, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol. 2011;29(17):2334–41. https://doi.org/10.1200/JCO.2010.32.5704.
Lambertini M, Ceppi M, Poggio F, Peccatori FA, Azim HA Jr, Ugolini D, et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol. 2015;26(12):2408–19. https://doi.org/10.1093/annonc/mdv374.
Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015;372(10):923–32. https://doi.org/10.1056/NEJMoa1413204.
Munhoz RR, Pereira AA, Sasse AD, Hoff PM, Traina TA, Hudis CA, et al. Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: a systematic review and meta-analysis. JAMA Oncol. 2016;2(1):65–73. https://doi.org/10.1001/jamaoncol.2015.3251.
•• Levine J, Canada A, Stern CJ. Fertility preservation in adolescents and young adults with cancer. J Clin Oncol. 2010;28(32):4831–41. https://doi.org/10.1200/JCO.2009.22.8312. This article well summarized different fertility preservation options for AYA cancer patients.
Wallace WH. Oncofertility and preservation of reproductive capacity in children and young adults. Cancer. 2011;117(10 Suppl):2301–10. https://doi.org/10.1002/cncr.26045.
van Casteren NJ, van Santbrink EJ, van Inzen W, Romijn JC, Dohle GR. Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients. Fertil Steril. 2008;90(6):2245–50. https://doi.org/10.1016/j.fertnstert.2007.10.055.
Valli H, Phillips BT, Shetty G, Byrne JA, Clark AT, Meistrich ML, et al. Germline stem cells: toward the regeneration of spermatogenesis. Fertil Steril. 2014;101(1):3–13. https://doi.org/10.1016/j.fertnstert.2013.10.052.
Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117(5):1105–13. https://doi.org/10.1097/AOG.0b013e31821188ad.
Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366(21):1998–2007. https://doi.org/10.1056/NEJMoa1110855.
Orenstein GA, Lewis L. Eriksons stages of psychosocial development. Treasure Island: StatPearls; 2020.
Bates G, Taub RN, West HJ. Intimacy, body image, and cancer. JAMA Oncol. 2016;2(12):1667. https://doi.org/10.1001/jamaoncol.2016.1196.
Landwehr MS, Watson SE, Macpherson CF, Novak KA, Johnson RH. The cost of cancer: a retrospective analysis of the financial impact of cancer on young adults. Cancer Med. 2016;5(5):863–70. https://doi.org/10.1002/cam4.657.
Thom B, Benedict C, Friedman DN, Kelvin JF. The intersection of financial toxicity and family building in young adult cancer survivors. Cancer. 2018;124(16):3284–9. https://doi.org/10.1002/cncr.31588.
Kaul S, Smits-Seemann RR, Zamora ER, Spraker-Perlman H, Boyle KJ, Kirchhoff AC. Adolescent and young adult cancer survivors’ valuation of post-treatment recommended care. J Adolesc Young Adult Oncol. 2017;6(1):127–33. https://doi.org/10.1089/jayao.2016.0054.
Peteet JR. Cancer and the meaning of work. Gen Hosp Psychiatry. 2000;22(3):200–5. https://doi.org/10.1016/s0163-8343(00)00076-1.
Parsons HM, Schmidt S, Harlan LC, Kent EE, Lynch CF, Smith AW, et al. Young and uninsured: insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study. Cancer. 2014;120(15):2352–60. https://doi.org/10.1002/cncr.28685.
Dahl AA, Fosså SD, Lie HC, Loge JH, Reinertsen KV, Ruud E, et al. Employment status and work ability in long-term young adult cancer survivors. J Adolesc Young Adult Oncol. 2019;8(3):304–11. https://doi.org/10.1089/jayao.2018.0109.
Parsons SK, Phipps S, Sung L, Baker KS, Pulsipher MA, Ness KK. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: health-related quality of life, functional, and neurocognitive outcomes. Biol Blood Marrow Transplant. 2012;18(2):162–71. https://doi.org/10.1016/j.bbmt.2011.12.501.
•• Jones JM, Fitch M, Bongard J, Maganti M, Gupta A, D'Agostino N, et al. The needs and experiences of post-treatment adolescent and young adult cancer survivors. J Clin Med. 2020;9(5). https://doi.org/10.3390/jcm9051444. This national Canadian survey describes the physical and psychosocial concerns of AYA cancer survivors post-treatment and suggests proactive measures to eliminate barriers.
Klaver KM, Duijts SFA, Engelhardt EG, Geusgens CAV, Aarts MJB, Ponds R, et al. Cancer-related cognitive problems at work: experiences of survivors and professionals. J Cancer Surviv. 2020;14(2):168–78. https://doi.org/10.1007/s11764-019-00830-5.
Parsons HM, Harlan LC, Lynch CF, Hamilton AS, Wu XC, Kato I, et al. Impact of cancer on work and education among adolescent and young adult cancer survivors. J Clin Oncol. 2012;30(19):2393–400. https://doi.org/10.1200/jco.2011.39.6333.
Bellizzi KM, Smith A, Schmidt S, Keegan TH, Zebrack B, Lynch CF, et al. Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult. Cancer. 2012;118(20):5155–62. https://doi.org/10.1002/cncr.27512.
Brauer ER, Pieters HC, Ganz PA, Landier W, Pavlish C, Heilemann MV. “From snail mode to rocket ship mode”: adolescents and young adult’ experiences of returning to work and school after hematopoietic cell transplantation. J Adolesc Young Adult Oncol. 2017;6(4):551–9. https://doi.org/10.1089/jayao.2017.0025.
Stergiou-Kita M, Pritlove C, Holness DL, Kirsh B, van Eerd D, Duncan A, et al. Am I ready to return to work? Assisting cancer survivors to determine work readiness. J Cancer Surviv. 2016;10(4):699–710. https://doi.org/10.1007/s11764-016-0516-9.
•• Penn A, Kuperberg A. Psychosocial support in adolescents and young adults with cancer. Cancer J. 2018;24(6):321–7. https://doi.org/10.1097/ppo.0000000000000339. This article focuses on methods by which psychosocial support for AYAs can be provided at diagnosis, during treatment, and in survivorship.
Goossens J, Delbaere I, Beeckman D, Verhaeghe S, Van Hecke A. Communication difficulties and the experience of loneliness in patients with cancer dealing with fertility issues: a qualitative study. Oncol Nurs Forum. 2015;42(1):34–43. https://doi.org/10.1188/15.Onf.34-43.
Wesley KM, Fizur PJ. A review of mobile applications to help adolescent and young adult cancer patients. Adolesc Health Med Ther. 2015;6:141–8. https://doi.org/10.2147/ahmt.S69209.
Levin NJ, Zebrack B, Cole SW. Psychosocial issues for adolescent and young adult cancer patients in a global context: a forward-looking approach. Pediatr Blood Cancer. 2019;66(8):e27789. https://doi.org/10.1002/pbc.27789.
• Smith AW, Keegan T, Hamilton A, Lynch C, Wu XC, Schwartz SM, et al. Understanding care and outcomes in adolescents and young adult with cancer: a review of the AYA HOPE study. Pediatr Blood Cancer. 2019;66(1):e27486. https://doi.org/10.1002/pbc.27486. This review summarizes data from multiple manuscripts published from the AYA Hope study and highlights the research gaps in the AYA cancer population.
Zebrack B, Bleyer A, Albritton K, Medearis S, Tang J. Assessing the health care needs of adolescent and young adult cancer patients and survivors. Cancer. 2006;107(12):2915–23. https://doi.org/10.1002/cncr.22338.
Lee JS, DuBois SG, Coccia PF, Bleyer A, Olin RL, Goldsby RE. Increased risk of second malignant neoplasms in adolescents and young adults with cancer. Cancer. 2016;122(1):116–23. https://doi.org/10.1002/cncr.29685.
Ng AK, Kenney LB, Gilbert ES, Travis LB. Secondary malignancies across the age spectrum. Semin Radiat Oncol. 2010;20(1):67–78. https://doi.org/10.1016/j.semradonc.2009.09.002.
Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005;97(19):1428–37. https://doi.org/10.1093/jnci/dji290.
Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005;97(18):1354–65. https://doi.org/10.1093/jnci/dji278.
Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst. 2007;99(3):206–14. https://doi.org/10.1093/jnci/djk029.
Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol. 2010;28(30):4649–57. https://doi.org/10.1200/JCO.2010.29.9362.
Fossa SD, Gilbert E, Dores GM, Chen J, McGlynn KA, Schonfeld S, et al. Noncancer causes of death in survivors of testicular cancer. J Natl Cancer Inst. 2007;99(7):533–44. https://doi.org/10.1093/jnci/djk111.
Abouassaly R, Fossa SD, Giwercman A, Kollmannsberger C, Motzer RJ, Schmoll HJ, et al. Sequelae of treatment in long-term survivors of testis cancer. Eur Urol. 2011;60(3):516–26. https://doi.org/10.1016/j.eururo.2011.05.055.
De Bruin ML, Dorresteijn LD, van't Veer MB, Krol AD, van der Pal HJ, Kappelle AC, et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst. 2009;101(13):928–37. https://doi.org/10.1093/jnci/djp147.
•• McCabe MS, Partridge AH, Grunfeld E, Hudson MM. Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol. 2013;40(6):804–12. https://doi.org/10.1053/j.seminoncol.2013.09.004. This article promotes the risk-based survivorship model for AYAs that is considered to be a benchmark for AYA survivorship.
Kinahan KE, Sanford S, Sadak KT, Salsman JM, Danner-Koptik K, Didwania A. Models of cancer survivorship care for adolescents and young adults. Semin Oncol Nurs. 2015;31(3):251–9. https://doi.org/10.1016/j.soncn.2015.05.005.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Palliative Medicine
About this article
Cite this article
Jin, Z., Griffith, M.A. & Rosenthal, A.C. Identifying and Meeting the Needs of Adolescents and Young Adults with Cancer. Curr Oncol Rep 23, 17 (2021). https://doi.org/10.1007/s11912-020-01011-9